Chu X, Tian W, Ning J, Zhou R#. Efficacy and Safety of Personalized Optimal PD-(L)1 Combinations in Advanced NSCLC: A Network Meta-Analysis. J Natl Cancer Inst. 2024 Oct 1;116(10):1571-1586. (JCR1区 IF=10.3)
发布时间：2026-10-01
点击次数：
是否译文：否
上一条： Zeng Q, Chu X, Xiao G, Zhang J, Zhang Y, Long B, Yang L, Tan Z, Zhou R#. The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis. CNS Neurosci Ther. 2024 Nov;30(11):e70102. doi: 10.1111/cns.70102. PMID: 39500635 (JCR1区 IF=7.04)
下一条： Tian W, Niu L, Shi Y#, Li S, Zhou R#. First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis. Ther Adv Med Oncol. 2024 May 30;16:17588359241255613. doi: 10.1177/17588359241255613. PMID: 38827178 (JCR2区 IF=4.9)